We are live on ! Find out more
JIC

Johnson Investment Counsel Portfolio holdings

AUM $13.7B
1-Year Est. Return 21.52%
This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+21.52%
3 Year Est. Return
+66.26%
5 Year Est. Return
+83.65%
10 Year Est. Return
+316.44%
AUM
$10.3B
AUM Growth
+$94.1M
Cap. Flow
+$107M
Cap. Flow %
1.04%
Top 10 Hldgs %
33.09%
Holding
858
New
50
Increased
329
Reduced
274
Closed
69

Top Buys

Rank Stock Value
1
IEX icon
IDEX
IEX
+$35.7M
2
ABBV icon
AbbVie
ABBV
+$28.8M
3
PEP icon
PepsiCo
PEP
+$15.2M
4
MSFT icon
Microsoft
MSFT
+$14.2M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$12.7M

Top Sells

Rank Stock Value
1
HSY icon
Hershey
HSY
+$34.8M
2
ZBH icon
Zimmer Biomet
ZBH
+$29.2M
3
EL icon
Estee Lauder
EL
+$27M
4
SPGI icon
S&P Global
SPGI
+$13.7M
5
CMCSA icon
Comcast
CMCSA
+$7.26M

Sector Composition

Rank Sector Weight
1 Technology 16.71%
2 Financials 14.68%
3 Healthcare 8.49%
4 Industrials 8.38%
5 Consumer Staples 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMN icon
751
Eastman Chemical
EMN
$8.55B
$207K ﹤0.01%
2,267
+74
+3% +$7.59K
FDM icon
752
First Trust Dow Jones Select MicroCap Index Fund
FDM
$269M
$207K ﹤0.01%
+851
New +$57.9K
LW icon
753
Lamb Weston
LW
$7.23B
$207K ﹤0.01%
3,095
-1,514
-33% -$113K
SXI icon
754
Standex International
SXI
$3.99B
$206K ﹤0.01%
1,100
GDEN
755
DELISTED
Golden Entertainment
GDEN
$205K ﹤0.01%
6,500
CVLT icon
756
Commault Systems
CVLT
$5.82B
$205K ﹤0.01%
1,360
-543
-29% -$87.4K
HLI icon
757
Houlihan Lokey
HLI
$8.79B
$204K ﹤0.01%
+1,176
New +$207K
FCF icon
758
First Commonwealth Financial
FCF
$2.18B
$202K ﹤0.01%
11,939
BF.B icon
759
Brown-Forman Class B
BF.B
$12.8B
$202K ﹤0.01%
5,306
+3
+0.1% +$132
FXI icon
760
iShares China Large-Cap ETF
FXI
$4.26B
$201K ﹤0.01%
6,600
SAN icon
761
Banco Santander
SAN
$210B
$201K ﹤0.01%
44,055
+1,415
+3% +$6.8K
AHCO icon
762
AdaptHealth
AHCO
$739M
$198K ﹤0.01%
20,779
+5,189
+33% +$52.5K
CRGY icon
763
Crescent Energy
CRGY
$4.09B
$193K ﹤0.01%
+13,222
New +$179K
WEN icon
764
Wendy's
WEN
$1.41B
$187K ﹤0.01%
11,443
-82
-0.7% -$1.5K
AMX icon
765
America Movil
AMX
$70.6B
$182K ﹤0.01%
12,684
AQN icon
766
Algonquin Power & Utilities
AQN
$4.46B
$178K ﹤0.01%
40,000
+16,000
+67% +$77.2K
NVRI icon
767
Enviri
NVRI
$600M
$178K ﹤0.01%
23,102
-400
-2% -$3.34K
CX icon
768
Cemex
CX
$16.1B
$173K ﹤0.01%
30,625
NEO icon
769
NeoGenomics
NEO
$2.12B
$168K ﹤0.01%
+10,206
New +$159K
EVH icon
770
Evolent Health
EVH
$468M
$131K ﹤0.01%
11,607
+2,542
+28% +$44.7K
RPAY icon
771
Repay Holdings
RPAY
$320M
$127K ﹤0.01%
16,600
ALTM
772
DELISTED
Arcadium Lithium plc
ALTM
$125K ﹤0.01%
24,432
+935
+4% +$4.77K
WBD icon
773
Warner Bros
WBD
$68B
$123K ﹤0.01%
11,631
-2,284
-16% -$21.2K
WULF icon
774
TeraWulf
WULF
$8.41B
$113K ﹤0.01%
20,000
GERN icon
775
Geron
GERN
$1.01B
$108K ﹤0.01%
+30,496
New +$122K

Similar funds

Johnson Investment Counsel's Q4 2024 Portfolio in Review

As of Q4 2024, Johnson Investment Counsel held 858 positions worth $10.3B, up 0.93% from $10.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Johnson Investment Counsel's Q4 2024 filing shows 50 new, 329 increased, 274 reduced and 69 closed positions. Its largest new stake was AbbVie: 156,468 shares worth $27.8M. The largest sale was Hershey, an estimated $34.8M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Johnson Investment Counsel's largest Q4 2024 buy was AbbVie: 156,468 shares worth $27.8M.
  • Johnson Investment Counsel added most to IDEX in Q4 2024, an estimated $35.7M increase.
  • Johnson Investment Counsel's biggest Q4 2024 reduction was Hershey, cutting an estimated $34.8M.
  • Johnson Investment Counsel fully exited Generac Holdings in Q4 2024, selling an estimated $3.56M.
  • Johnson Investment Counsel's ten largest holdings make up 33% of its $10.3B portfolio in Q4 2024.
  • Johnson Investment Counsel opened 50 new positions and closed 69 in Q4 2024.
  • Johnson Investment Counsel's portfolio value rose 0.93% quarter-over-quarter to $10.3B.

Based on Johnson Investment Counsel's 13F filing for Q4 2024, filed 7 Feb 2025.